Patterns of treatment in men with intermediate-, high-, and very high-risk prostate cancer according to their modelled life expectancy

被引：0
|
作者：
Irenaeus, S. [1 ]
Garmo, H. [2 ]
Gedeborg, R. [2 ]
Robinson, D. [3 ]
Stattin, P. [2 ]
Beckmann, K. [4 ]
机构：
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[2] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[3] Highland Hosp, Dept Urol, Eksjo, Sweden
[4] Univ South Australia, Canc Epidemiol & Populat Hlth Res Grp, Adelaide, SA, Australia
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0424
引用
收藏
页码：S1265 / S1266
页数：2
相关论文
共 50 条
  • [41] Brachytherapy Increased use in patients with intermediate- and high-risk prostate cancers
    Ali, Sanna
    Esper, Peg
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 321 - 328
  • [42] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Ali S. Alzahrani
    Noha Mukhtar
    Endocrine, 2022, 78 : 531 - 542
  • [43] ADJUVANT RADIATION REFERRAL PATTERNS IN MEN WITH HIGH-RISK PROSTATE CANCER
    Ryan, Stephen
    Mills, Gregory
    Cheney, Matthew
    Hayn, Matthew
    JOURNAL OF UROLOGY, 2017, 197 (04): : E45 - E45
  • [44] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Alzahrani, Ali S.
    Mukhtar, Noha
    ENDOCRINE, 2022, 78 (03) : 531 - 542
  • [46] Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients
    Katz, A.
    Kang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E250 - E250
  • [47] Quantitative imaging parameters to predict local staging of prostate cancer in intermediate- to high-risk patients
    Laudicella, R.
    Skawran, S.
    Ferraro, D. A.
    Muhlematter, U.
    Maurer, A.
    Grunig, H.
    Donati, O.
    Eberli, D.
    Burger, I. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S206 - S206
  • [48] Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
    J V Hegde
    D J Margolis
    P-C Wang
    R E Reiter
    J Huang
    M L Steinberg
    M Kamrava
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 241 - 248
  • [49] Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
    Laudicella, Riccardo
    Skawran, Stephan
    Ferraro, Daniela A.
    Muhlematter, Urs J.
    Maurer, Alexander
    Grunig, Hannes
    Ruschoff, Hendrik J.
    Rupp, Niels
    Donati, Olivio
    Eberli, Daniel
    Burger, Irene A.
    INSIGHTS INTO IMAGING, 2022, 13 (01)
  • [50] Is Clinical Stage T2c Prostate Cancer an Intermediate- or High-Risk Disease?
    Klaassen, Zachary
    Singh, Abhay A.
    Howard, Lauren E.
    Feng, Zhaoyong
    Trock, Bruce
    Terris, Martha K.
    Aronson, William J.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Kane, Christopher J.
    Partin, Alan
    Han, Misop
    Freedland, Stephen J.
    CANCER, 2015, 121 (09) : 1414 - 1421
12345